Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

19.10

+0.34 (1.81%)

At close: Jul 29, 2026, 4:00 PM EDT

19.40

+0.30 (1.57%)

After-hours: Jul 29, 2026, 7:34 PM EDT

Amneal Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,046	3,019	2,794	2,394	2,212	2,094
Revenue Growth	7.62%	8.05%	16.73%	8.20%	5.67%	5.08%
Gross Profit	1,178	1,113	1,020	820.57	784.71	768.97
Operating Income	435.52	394.1	249.33	204.37	-94.93	152.72
Net Income	122.12	72.06	-116.89	-83.99	-129.99	10.62
Earnings Per Share	0.38	0.22	-0.38	-0.48	-0.86	0.07
EPS Growth	-	-	-	-	-	-88.52%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Affordable Medicines Net	1,754	1,746	1,685	1,471	1,432	1,366
Specialty Net	553.48	528.51	445.75	390.46	374.12	378.32
AvKARE Net	738.33	744.73	662.95	531.75	406.11	349.01
Revenue (Total)	3,046	3,019	2,794	2,394	2,212	2,094

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	201.83	310.87	118.42	99.11	35.23	256.74
Total Debt	2,696	2,689	2,593	2,751	2,845	2,876
Net Cash (Debt)	-2,495	-2,378	-2,475	-2,651	-2,810	-2,619
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.76	-7.32	-8.01	-15.05	-18.59	-17.26

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	305.84	339.99	295.1	345.58	65.1	241.82
Capital Expenditures	-98.58	-98.84	-60.34	-46.8	-48.8	-50.94
Free Cash Flow	207.26	241.15	234.76	298.78	16.31	190.88
Free Cash Flow Growth	-14.54%	2.72%	-21.43%	1732.42%	-91.46%	-39.82%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	38.66%	36.88%	36.52%	34.28%	35.47%	36.73%
Operating Margin	14.30%	13.05%	8.92%	8.54%	-4.29%	7.29%
Pretax Margin	5.97%	4.61%	-1.97%	-1.68%	-11.22%	1.50%
Profit Margin	5.95%	4.24%	-2.64%	-2.04%	-11.52%	0.96%
FCF Margin	6.80%	7.99%	8.40%	12.48%	0.74%	9.12%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	51.47	57.27	-	-	-	68.43
Forward PE	19.55	15.04	11.69	11.92	2.71	5.65
P/FCF Ratio	29.40	16.44	10.45	6.23	18.49	3.75
PS Ratio	2.00	1.31	0.88	0.78	0.14	0.34